As reported in PharmTech Talk's summary of new report from Biotechnology Information Institute, there were 16 new biopharmaceutical entities approved in 2009. This is up from 10 the prior year. Only 5 of these were from US based companies with the rest coming from Europe.
A recent JAMA article suggest this may be due to a decrease in R&D spending in US companies since 2003.
Posted by Bruce Lehr Jan 18, 2010.
Comments